BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 19620560)

  • 1. Granuloma annulare treated with rifampin, ofloxacin, and minocycline combination therapy.
    Marcus DV; Mahmoud BH; Hamzavi IH
    Arch Dermatol; 2009 Jul; 145(7):787-9. PubMed ID: 19620560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monthly rifampicin, ofloxacin, and minocycline therapy for generalized and localized granuloma annulare.
    Garg S; Baveja S
    Indian J Dermatol Venereol Leprol; 2015; 81(1):35-9. PubMed ID: 25566894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
    Mane I; Cartel JL; Grosset JH
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple antibiotic combination therapy may improve but not resolve granuloma annulare.
    Simpson B; Foster S; Ku JH; Simpson EL; Ehst BD
    Dermatol Ther; 2014; 27(6):343-7. PubMed ID: 25053171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy.
    Villahermosa LG; Fajardo TT; Abalos RM; Cellona RV; Balagon MV; Dela Cruz EC; Tan EV; Walsh GP; Walsh DS
    Am J Trop Med Hyg; 2004 Feb; 70(2):197-200. PubMed ID: 14993633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
    Majumder V; Saha B; Hajra SK; Biswas SK; Saha K
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-dose rifampicin, oflaxicin and minocycline (ROM) therapy for single leprosy lesions.
    Ramu G
    Lepr Rev; 1998 Mar; 69(1):78-82. PubMed ID: 9628098
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapid improvement of recalcitrant disseminated granuloma annulare upon treatment with the tumour necrosis factor-alpha inhibitor, infliximab.
    Hertl MS; Haendle I; Schuler G; Hertl M
    Br J Dermatol; 2005 Mar; 152(3):552-5. PubMed ID: 15787827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multibacillary leprosy: follow up observations on 19 patients treated with 12 monthly doses of rifampicin, ofloxacin and minocycline therapy in Agra.
    Kumar A; Girdhar BK
    Indian J Dermatol Venereol Leprol; 2014; 80(2):156-9. PubMed ID: 24685858
    [No Abstract]   [Full Text] [Related]  

  • 10. Granuloma annulare.
    Goucha S; Khaled A; Kharfi M; Fazaa B; Zermani R; Ben Jilani S; Kamoun MR
    G Ital Dermatol Venereol; 2008 Dec; 143(6):359-63. PubMed ID: 19169208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative clinico-pathological study of single dose ROM in paucibacillary leprosy patients with 1-3 skin lesions.
    Deshmukh AR; Dhurat RS; Jerajani HR
    Indian J Lepr; 2003; 75(3):209-17. PubMed ID: 15267190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose ROM treatment for multilesion paucibacillary leprosy--further observations.
    Revankar CR; Bulchand HO; Pai VV; Ganapati R
    Int J Lepr Other Mycobact Dis; 2002 Mar; 70(1):37-8. PubMed ID: 12120040
    [No Abstract]   [Full Text] [Related]  

  • 13. Lesional characteristics and histopathology in paucibacillary leprosy patients with 2 or 3 skin lesions: comparison between ROM and PB-MDT regimens.
    Emmanuel M; Gupte MD
    Indian J Lepr; 2005; 77(1):19-25. PubMed ID: 16173416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-dose treatment for paucibacillary leprosy; field implications.
    Revankar CR; Pai VV; Samy MS; Ganapati R
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):312-4. PubMed ID: 10575415
    [No Abstract]   [Full Text] [Related]  

  • 15. Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up.
    Ganapati R; Revankar CR; Pai VV; Kingsley S
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):308-9. PubMed ID: 10575413
    [No Abstract]   [Full Text] [Related]  

  • 16. Single-dose treatment for paucibacillary leprosy; clinical problems and management.
    Pai VV; Bulchand HO; Revankar CR; Ganapati R
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):310-2. PubMed ID: 10575414
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparative trial of single dose chemotherapy in paucibacillary leprosy patients with two to three skin lesions.
    2-3 Lesion Multicentre Trial Group
    Indian J Lepr; 2001; 73(2):131-43. PubMed ID: 11579649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose treatment for single lesion leprosy; histopathological observations.
    Shinde A; Khopkar U; Pai VV; Ganapati R
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):328-30. PubMed ID: 11221099
    [No Abstract]   [Full Text] [Related]  

  • 19. Single lesion paucibacillary leprosy: baseline profile of the Brazilian Multicenter Cohort Study.
    Martelli CM; Stefani MM; Gomes MK; Rebello PF; Peninni S; Narahashi K; Maroclo AL; Costa MB; Silva SA; Sacchetim SC; Nery JA; Salles AM; Gillis TP; Krahenbuhl JL; Andrade AL
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):247-57. PubMed ID: 11221086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy for granuloma annulare: more than a shot in the dark.
    Weisenseel P; Kuznetsov AV; Molin S; Ruzicka T; Berking C; Prinz JC
    Dermatology; 2008; 217(4):329-32. PubMed ID: 18799877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.